Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Longitudinal Real-world Clinical Outcomes Study on Symplicity Renal Denervation

NCT: NCT07174622 · RECRUITING

NCT IDNCT07174622
StatusRECRUITING
Start Date2025-10-28
Completion2029-06

Brief Summary

This observational study will assess the long-term effectiveness of the RDN procedure for lowering blood pressure in Medicare patients with uncontrolled hypertension. This research will be conducted using de-identified electronic health records (EHR) and administrative health insurance claims data. Patients are enrolled through the submission of claims or encounter data to CMS.

Frequently Asked Questions

What is Longitudinal Real-world Clinical Outcomes Study on Symplicity Renal Denervation?

Longitudinal Real-world Clinical Outcomes Study on Symplicity Renal Denervation is a clinical trial registered under NCT07174622. Current status: RECRUITING.

What is the status of NCT07174622?

The current status of NCT07174622 (Longitudinal Real-world Clinical Outcomes Study on Symplicity Renal Denervation) is: RECRUITING.

When did Longitudinal Real-world Clinical Outcomes Study on Symplicity Renal Denervation start?

Longitudinal Real-world Clinical Outcomes Study on Symplicity Renal Denervation started on 2025-10-28.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑